Historical record - last NADAC effective date: 2/18/2015
Product Information
PERPHEN-AMITRIP 4 MG-50 MG TAB is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $1.9732 per EA under NDC 00378007301. Its NADAC has been published 121 times since Nov 28, 2013.
FDA first approved this application on Nov 10, 1988.
Strength
50; 4 mg/1; mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378007301
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
2/18/2015
Active Ingredients
AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINEApproval Type
Generic (ANDA)
FDA Application
ANDA071443FDA Approved
11/10/1988
On Market Since
11/10/1988
Pharmacological Classes
Price Statistics
The NADAC for PERPHEN-AMITRIP 4 MG-50 MG TAB has been published 121 times since Nov 28, 2013, and over the history we have for it it has risen 47.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.9732 per EA |
|---|---|
| All-time high | $1.9732 (Mar 16, 2016) |
| All-time low | $1.3325 (May 21, 2014) |
| Median price | $1.9194 |
| Average price | $1.7622 |
| Largest weekly change | +44.1% (Aug 20, 2014) |
| Weeks tracked | 121 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+47.1%
Last surveyed Mar 16, 2016 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the perphenazine and amitriptyline hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of PERPHEN-AMITRIP 4 MG-50 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for PERPHEN-AMITRIP 4 MG-50 MG TAB, manufactured by Mylan Pharmaceuticals Inc., is $1.9732 per EA (NDC 00378007301), effective Mar 16, 2016.
How has the price of PERPHEN-AMITRIP 4 MG-50 MG TAB changed over time?
Over the history we have for it, the NADAC for PERPHEN-AMITRIP 4 MG-50 MG TAB has risen 47.1%. It has been tracked across 121 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for PERPHEN-AMITRIP 4 MG-50 MG TAB?
Since Nov 28, 2013, the NADAC for PERPHEN-AMITRIP 4 MG-50 MG TAB has ranged from a low of $1.3325 (May 21, 2014) to a high of $1.9732 (Mar 16, 2016), with a median of $1.9194 per EA.
Are there cheaper alternatives to PERPHEN-AMITRIP 4 MG-50 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of PERPHEN-AMITRIP 4 MG-50 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures PERPHEN-AMITRIP 4 MG-50 MG TAB?
PERPHEN-AMITRIP 4 MG-50 MG TAB (NDC 00378007301) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.